Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Bras Nefrol ; 44(2): 215-223, 2022.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-35014666

RESUMEN

INTRODUCTION: Treatment for Helicobacter pylori (H. pylori) infection is recommended in transplant candidates due to the association between this infection and gastrointestinal disorders, which could significantly increase morbidity after renal transplantation with the use of immunosuppression. The objective of this study was to analyze the rate of eradication of H. pylori after antimicrobial treatment in chronic kidney disease patients who are candidates for kidney transplantation. METHODS: A multicenter prospective cohort study was conducted. All adult chronic kidney disease patients seen at our institution were included. In the pre-transplantation evaluation, 83 patients underwent an upper gastrointestinal endoscopy with 2 diagnostic methods to detect H. pylori: histology and the rapid urease test. In total, 33 patients with H. pylori infection received treatment with 20 mg omeprazole, 500 mg amoxicillin, and 500 mg clarithromycin once daily for 14 days. Another upper gastrointestinal endoscopy was performed 8 to 12 weeks after the end of treatment to check for healing. RESULTS: The study showed a prevalence of H. pylori in 51 (61.4%) patients. Histology was positive in 50 (98%) patients and the rapid urease test was positive in 31 (60.8%). The infection eradication rate was 48.5% (16 patients). CONCLUSIONS: There was a high prevalence rate of H. pylori and a low eradication rate after the long-term antimicrobial triple scheme used. The association of the rapid urease test with gastric mucosa histology did not increase the detection rate of H. pylori.


Asunto(s)
Antiinfecciosos , Infecciones por Helicobacter , Helicobacter pylori , Trasplante de Riñón , Insuficiencia Renal Crónica , Adulto , Antibacterianos/uso terapéutico , Antiinfecciosos/uso terapéutico , Quimioterapia Combinada , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Estudios Prospectivos , Insuficiencia Renal Crónica/tratamiento farmacológico , Resultado del Tratamiento , Ureasa/uso terapéutico
2.
J. bras. nefrol ; 44(2): 215-223, June 2022. tab, graf
Artículo en Inglés | LILACS-Express | LILACS | ID: biblio-1386035

RESUMEN

Abstract Introduction: Treatment for Helicobacter pylori (H. pylori) infection is recommended in transplant candidates due to the association between this infection and gastrointestinal disorders, which could significantly increase morbidity after renal transplantation with the use of immunosuppression. The objective of this study was to analyze the rate of eradication of H. pylori after antimicrobial treatment in chronic kidney disease patients who are candidates for kidney transplantation. Methods: A multicenter prospective cohort study was conducted. All adult chronic kidney disease patients seen at our institution were included. In the pre-transplantation evaluation, 83 patients underwent an upper gastrointestinal endoscopy with 2 diagnostic methods to detect H. pylori: histology and the rapid urease test. In total, 33 patients with H. pylori infection received treatment with 20 mg omeprazole, 500 mg amoxicillin, and 500 mg clarithromycin once daily for 14 days. Another upper gastrointestinal endoscopy was performed 8 to 12 weeks after the end of treatment to check for healing. Results: The study showed a prevalence of H. pylori in 51 (61.4%) patients. Histology was positive in 50 (98%) patients and the rapid urease test was positive in 31 (60.8%). The infection eradication rate was 48.5% (16 patients). Conclusions: There was a high prevalence rate of H. pylori and a low eradication rate after the long-term antimicrobial triple scheme used. The association of the rapid urease test with gastric mucosa histology did not increase the detection rate of H. pylori.


Resumo Introdução: Recomenda-se o tratamento da infecção por Helicobacter pylori (H. pylori) nos candidatos a transplante devido à associação entre esta infecção e distúrbios gastrointestinais, que podem aumentar significativamente a morbidade após transplante renal com o uso de imunossupressão. O objetivo deste estudo foi analisar a taxa de erradicação do H. pylori após tratamento antimicrobiano em pacientes com doença renal crônica, candidatos a transplante renal. Métodos: Realizou-se um estudo de coorte prospectivo multicêntrico. Incluímos todos os pacientes adultos com doença renal crônica atendidos em nossa instituição. Na avaliação pré-transplante, 83 pacientes foram submetidos a uma endoscopia digestiva alta com 2 métodos diagnósticos para detecção do H. pylori: histologia e teste rápido de urease. No total, 33 pacientes com infecção por H. pylori receberam tratamento com 20 mg de omeprazol, 500 mg de amoxicilina e 500 mg de claritromicina uma vez ao dia durante 14 dias. Outra endoscopia digestiva alta foi realizada 8 a 12 semanas após o término do tratamento para verificação da resposta. Resultados: O estudo mostrou prevalência de H. pylori em 51 (61,4%) pacientes. A histologia foi positiva em 50 (98%) pacientes e o teste rápido de urease foi positivo em 31 (60,8%). A taxa de erradicação da infecção foi 48,5% (16 pacientes). Conclusões: Após o esquema triplo antimicrobiano de longo prazo utilizado, houve uma alta taxa de prevalência de H. pylori e baixa taxa de erradicação. A associação do teste rápido de urease com a histologia da mucosa gástrica não aumentou a taxa de detecção do H. pylori.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA